<DOC>
	<DOCNO>NCT01067885</DOCNO>
	<brief_summary>The MARIS Register prospective , multicenter registry implantation superficial femoral artery ( SFA ) CE mark stent ( Maris / Invatec ) intend capture initial angiographic success , complication rate symptomatic relate revascularization follow clinical process duplex examination 6 12 month .</brief_summary>
	<brief_title>A Post-market Registry MARIS-stent ( Invatec ) Implanted Superficial Femoral Artery</brief_title>
	<detailed_description>Recent data suggest evidence reduce restenosis rate implantation self expand nitinol stent superficial femoral artery ( SFA ) compare implantation balloon expandable stent single balloon inflation ( ABSOLUTE study/FAST study ) . The purpose Maris Register evaluate primary nitinol stent implantation comer population diseased SFA . The MARIS Register prospective , multicenter registry implantation least one five nitinol stent ( Maris / Invatec ) SFA without limitation stenosis occlusion length . The registry include 998 patient 13 German investigational site . Clinical data capture electronic case report form The primary endpoint target lesion revascularization 12 month Secondary endpoint : - Restenosis rate &gt; 50 % accord ultrasound criterion - Restenosis rate &gt; 70 % accord ultrasound criterion - Location restenosis ( proximal , middle , distal AFS ) - Number stent fracture ( grade accord FESTO criterion ) - Procedure related complication rate - Vascular complication rate within 12 month - Amputations within 12 month - Deaths within 12 month In order measure restenosis peak systolic velocity ( PSV ) measure two section duplex ultrasound examination 6 12 month . First measurement perform 2cm proximal first stent , second measurement location maximum peak velocity lesions/all implant stent measure . The clinical status include patientÂ´s Fontaine classification .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Inclusion criterion stent implantation SFA possible exist SFA stenosis 70100 % ( visual estimation ) absence homodynamically relevant stenosis A. poplitea least one low limb run vessel Exclusion criterion pregnancy life expectancy le 1 year coagulation disorder chronic anticoagulation therapy active gastrointestinal bleeding thrombolytic therapy within 72 hour intervention hyperthyreosis severe contrast agent allergy allergy concomittant medication severe liver disease thrombus target lesion target lesion extend A. poplitea severe calcification target vessel , successful predilatation feasible</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Nitinol Stent</keyword>
	<keyword>Superficial femoral artery</keyword>
	<keyword>SFA</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>peripheral artery disease</keyword>
	<keyword>peripheral artery obstructive disease</keyword>
	<keyword>PAOD</keyword>
	<keyword>PAD</keyword>
	<keyword>Peripheral Vascular Disease</keyword>
</DOC>